Is Eli Lilly and Company (LLY) stock halal?

Yes, under our AAOIFI-based methodology Eli Lilly and Company passes the business-activity and financial-ratio screens as shown on this page (data as of 2026-03-31). Check the dated ratio table before investing; ratios move with the share price.

Does Eli Lilly and Company pass the AAOIFI financial ratio screen?

As of 2026-03-31: interest-bearing debt is 4.1% of market cap (limit < 30%); cash plus interest-bearing securities is 0.5% (limit < 30%). The impermissible-income line is verified against the annual filing where noted on this page.

Is Eli Lilly and Company held in halal ETFs like SPUS or HLAL?

Yes — as of our last check, Eli Lilly and Company is held by HLAL. ETF inclusion confirms it passed those funds' Shariah screens at the holdings date cited in the sources below.

Do I need to purify dividends from Eli Lilly and Company?

Yes, in most cases. Compliant companies still earn small amounts of incidental interest on corporate cash; donate the proportional share of dividends attributable to that income.

Is Eli Lilly Stock Halal? Eli Lilly and Company (LLY) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 4.1% of market cap and cash plus interest-bearing securities 0.5% — both inside the 30% AAOIFI thresholds. It is independently held by Shariah-screened ETF HLAL, confirming it passes professional screens. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified. Reviewed 2026-06-15. Published by HalalWallet.

Is Eli Lilly Stock Halal?

Q: Is Eli Lilly Stock Halal?

All 4 halal screening authorities with a published position rate Eli Lilly and Company halal. Halal: Eli Lilly and Company (LLY) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 4.1% of market cap and cash plus interest-bearing securities 0.5% — both inside the 30% AAOIFI thresholds. It is independently held by Shariah-screened ETF HLAL, confirming it passes professional screens. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified. (Financial data as of 2026-03-31; basis: AAOIFI Shariah standards.)

Q: Is Eli Lilly and Company held in halal ETFs like SPUS or HLAL?

Yes — as of our last check, Eli Lilly and Company is held by HLAL. ETF inclusion confirms it passed those funds' Shariah screens at the holdings date cited in the sources below.

Q: Do I need to purify dividends from Eli Lilly and Company?

Yes, in most cases. Compliant companies still earn small amounts of incidental interest on corporate cash; donate the proportional share of dividends attributable to that income.

Eli Lilly and Company · LLY · NYSE

HalalGenerally permissible4 authorities agree

All 4 halal screening authorities with a published position rate Eli Lilly and Company halal.

Eli Lilly and Company (LLY) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 4.1% of market cap and cash plus interest-bearing securities 0.5% — both inside the 30% AAOIFI thresholds. It is independently held by Shariah-screened ETF HLAL, confirming it passes professional screens. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified.

Financial data as of 2026-03-31 · Screening basis: AAOIFI · Last reviewed 2026-06-15

HalalWallet is not a Shariah authority and does not issue religious rulings. We compile the most complete public record of what Shariah scholars, screening authorities, and mainstream standards say — reproduced from primary sources with dates and citations — and let you decide.

Do the halal screening authorities agree?

Authorities agree4 of 5 authorities with a published position

HalalWallet (AAOIFI)· Halal
Musaffa· Halal
Zoya· Halal
Wahed (HLAL ETF)· Halal

All 4 halal screening authorities with a published position rate Eli Lilly and Company halal.

Stances are normalized from each authority's own dated public position. Disagreement usually reflects a methodology or standard difference (ratio timing, market-cap vs total-assets denominator), not an error. For the fund screens (Wahed/HLAL, SP Funds/SPUS), only a confirmed holding that passed the fund's screen counts as a pass — a non-holding is left blank because absence can reflect index scope.

Is Eli Lilly Stock Halal?

All 4 halal screening authorities with a published position rate Eli Lilly and Company halal. Eli Lilly and Company (LLY) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 4.1% of market cap and cash plus interest-bearing securities 0.5% — both inside the 30% AAOIFI thresholds. It is independently held by Shariah-screened ETF HLAL, confirming it passes professional screens. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified.

Interest-bearing debt / market cap: 4.1% (< 30%) — Pass
Cash + interest-bearing securities / market cap: 0.5% (< 30%) — Pass
Impermissible income / total revenue: 0.2% (< 5%) — Pass
Mainstream Shariah standards disagree on this company — see the cross-standard table below.
Financial ratios sourced from filings as of 2026-03-31.

How we read the evidence

HalalWallet's editorial synthesis of the screens, scholar positions, and sources documented on this page — not a religious ruling.

Eli Lilly is a clean case for halal investors. It is a pure-play pharmaceutical company — its business is discovering, manufacturing, and selling prescription medicines, most prominently the Mounjaro and Zepbound diabetes-and-obesity franchise that has driven its recent growth. Producing and selling medicine is a permissible activity, so the business-activity screen passes without complication, and the stock is held by the Wahed FTSE USA Shariah ETF (HLAL), which independently confirms it clears the FTSE Shariah screen.

The financial ratios are comfortably inside AAOIFI limits. Eli Lilly carries modest interest-bearing debt relative to its very large market capitalization, holds little excess interest-bearing cash, and earns only a tiny sliver of interest income — about 0.2% of revenue on our screen, with independent screeners reporting figures in the 0.26%–0.42% range. All three of these are far below their thresholds, which is why screeners including Zoya, Musaffa, and ShariaPortfolio all classify the stock as compliant.

The practical takeaway: Eli Lilly passes both the business and financial screens cleanly today. As always, a pass is dated — ratios move with the share price and new filings — so check the data-as-of date on this page, and purify the small proportional share of any dividends attributable to incidental interest income. Avoid margin and options on the position.

Business Activity Screen

Pass· impermissible revenue ≈ 0.2% (AAOIFI limit < 5%)

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and sells prescription medicines. Its revenue is concentrated in diabetes and obesity care (the Mounjaro and Zepbound tirzepatide franchise), along with oncology, immunology, and neuroscience drugs. Manufacturing and selling pharmaceuticals is a permissible business activity.

Core pharmaceutical revenue raises no business-screen issues. The only review point is interest income earned on corporate cash — roughly 0.2% of revenue on our screen (independent screeners report it in the 0.26%–0.42% range), far below the 5% AAOIFI threshold. Investors following standard purification practice should donate the proportional share of dividends attributable to that income. No alcohol, gambling, tobacco, or interest-based lending lines are disclosed in the 10-K.

Financial Ratio Screen

Screen	Value	AAOIFI limit	Result
Interest-bearing debt / market cap	4.1%	< 30%	Pass
Cash + interest-bearing securities / market cap	0.5%	< 30%	Pass
Impermissible income / total revenueInterest income $153.3M on $65.18B total revenue (Eli Lilly and Company FY2025 (fiscal year ended 2025-12-31, Form 10-K)) = 0.2% — under AAOIFI's 5% limit.	0.2%	< 5%	Pass

Spot market cap at research date (consider trailing average for borderline names). Data as of 2026-03-31 · thresholds per AAOIFI Shariah standards.

This verdict uses the AAOIFI standard — the most widely used and, at a 30% debt limit, the most conservative mainstream Shariah standard. Interest-bearing debt and interest-bearing securities each stay under 30% of market cap, and impermissible income under 5% of revenue. Other standards (Dow Jones Islamic, S&P Shariah, MSCI Islamic, FTSE Yasaar) use ~33% limits or screen against total assets, so a borderline company can be rated differently by each. How we screen & why screeners disagree →

How Eli Lilly screens across Shariah standards

The standards disagree on this company. It passes some Shariah screens and fails others — which is exactly why you may see a different answer in different apps. Our headline verdict uses AAOIFI, the strictest and most widely cited mainstream standard.

Standard	Debt	Cash & interest securities	Limit / basis	Result
AAOIFI (our standard)	4.1%	0.5%	< 30% of market cap	Pass
Dow Jones Islamic / S&P Shariah thresholdDow Jones and S&P apply this limit against a trailing 24–36-month average market cap; shown here on the same point-in-time market cap for comparison.	4.1%	0.5%	< 33% of market cap	Pass
MSCI Islamic / FTSE Yasaar basisTotal-assets denominator. MSCI/FTSE also apply entry/exit buffers and a receivables screen we do not reproduce.	37.2%	4.5%	< 33.33% of total assets	Fail

HalalWallet computation reproducing each standard's threshold and denominator from public filings (balance sheet as of 2026-03-31) — not the providers' licensed index determinations, which can differ. Debt is interest-bearing borrowings (operating leases excluded). The impermissible-income screen (< 5% of revenue) is common to all of these standards and is shown in the ratio table above. Dow Jones and S&P apply their limit against a trailing 24–36-month average market cap; MSCI and FTSE add entry/exit buffers and a receivables screen. Full methodology →

These companies pass under some mainstream standards and fail under others — the same pattern as this verdict. That is why two apps can show different answers.

AbbVieABBV